CECR2 and leukemia: However, our results showed that siRNA knockdown of CECR2 in 293 T cells as previously reported18 or CRISPR/cas9-derived inactivation of the CECR2 gene in haploid leukemia cells did not affect the cytotoxic activity of NVS-CECR2-1 on these cells.